CGNX (NASDAQ: CGNX) insider sales: 179,200 shares disclosed in Form 144
Rhea-AI Filing Summary
CGNX: A Form 144 disclosure reports proposed and completed sales of Common Stock by holders, including a proposed sale tied to an option and completed sales by Robert J. Willett. The excerpt lists a proposed transaction dated 05/06/2026 (option granted 02/20/2024) and completed sales on 02/12/2026 and 02/13/2026.
The completed transactions show 177,052 shares sold on 02/12/2026 for $10,300,974.15 and 2,148 shares sold on 02/13/2026 for $127,808.48. Shares outstanding are listed as 165,707,920 as of 05/06/2026.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed and recent Rule 144 sales and an option-related sale authorization.
The excerpt records a proposed sale dated 05/06/2026 linked to an option granted 02/20/2024, plus actual dispositions on 02/12/2026 (177,052 shares) and 02/13/2026 (2,148 shares). Cash amounts are shown for each disposition.
These entries are regulatory disclosures of sales activity; cash‑flow treatment indicates proceeds to the selling holders. Subsequent public filings may show additional context such as the identity of the selling broker or whether transactions satisfied Rule 144 holding-period conditions.